VVT Med Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-3.14	-1.04	-2.2
Depreciation & Amortization	0.1	0.1	0.09
Stock-Based Compensation	-	-	0.3
Other Operating Activities	0.31	0.14	0.33
Change in Accounts Receivable	0.01	0.01	0.01
Change in Inventory	-0.1	-0.02	-0.04
Change in Accounts Payable	-0.16	-0.07	-0.09
Change in Other Net Operating Assets	0.24	-0.02	0.2
Operating Cash Flow	-2.74	-0.91	-1.4
Capital Expenditures	-	-	-0
Investing Cash Flow	-	-	-0
Short-Term Debt Issued	-	0.38	0.39
Long-Term Debt Issued	-	0.71	1.16
Total Debt Issued	1.66	1.09	1.54
Long-Term Debt Repaid	-	-0.14	-0.13
Net Debt Issued (Repaid)	1.5	0.96	1.42
Issuance of Common Stock	2.17	0	0
Other Financing Activities	-	-	-0.13
Financing Cash Flow	3.67	0.96	1.28
Foreign Exchange Rate Adjustments	0.14	-0.02	0.04
Net Cash Flow	1.12	0.03	-0.08
Free Cash Flow	-2.74	-0.91	-1.4
Free Cash Flow Margin	-2441.96%	-185.16%	-3419.51%
Free Cash Flow Per Share	-0.59	-0.20	-0.32
Levered Free Cash Flow	-	-0.85	-
Unlevered Free Cash Flow	-	-0.6	-
Change in Working Capital	-0	-0.11	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.